Influence of acute hyperlipidemia to adipocyte-derived hormones in lean normotensive and subjects with metabolic syndrome

Diabetology and Metabolic Syndrome

Volumn 6, Issue 1, 2014, Pages

  Lopes, Heno F ^b,c   Klein, Richard L ^a   Timothy Garvey, W ^a   Goodfriend, Theodore ^d   Egan, Brent M ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c UNIVERSIDADE NOVE DE JULHO   (Brazil)

^d UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Adiponectin; ASP C3adesARG; Intralipid and heparin; Lean normotensives; Leptin; Metabolic syndrome subjects

Indexed keywords

ADIPONECTIN; C3ADESARG; COMPLEMENT COMPONENT C3A; GLUCOSE; HEPARIN; INSULIN; INTRALIPID; LEPTIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADIPOCYTE; ADULT; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; HORMONE BLOOD LEVEL; HUMAN; HYPERLIPIDEMIA; INSULIN SENSITIVITY; LEAN BODY WEIGHT; MALE; METABOLIC SYNDROME X; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

EID: 84989187398     PISSN: None     EISSN: 17585996     Source Type: Journal    
DOI: 10.1186/1758-5996-6-132     Document Type: Article

References (25)

1. Haynes WG: Interaction between leptin and sympathetic nervous system in hypertension. Curr Hypertens Rep 2000, 2:311-318.
2. Park HY, Kwon HM, Lim HJ, Hong BK, Lee JY, Park BE, Jang Y, Cho SY, Kim HS: Potential role of leptin in angiogenesis: leptin induces endothelial cell proliferation and expression of matrix metalloproteinases in vivo and in vitro. Exp Mol Med 2001, 33:95-102.
3. Matsubara M, Chiba H, Maruoka S, Katayose S: Elevated serum leptin concentrations in women with components of multiple risk factor clustering syndrome. J Atheroscler Thromb 2000, 7:231-237.
4. Maruyama I, Nakata M, Yamaji K: Effect of leptin in platelet and endothelial cells. Obesity and arterial thrombosis. Ann N Y Acad Sci 2000, 902:315-319.
5. Arita Y, Kihara S, Ouchi N, Maeda K, Kuriyama H, Okamoto Y, Kumada M, Hotta K, Nishida M, Takahashi M, Nakamura T, Shimomura I, Muraguchi M, Ohmoto Y, Funahashi T, Matsuzawa Y: Adipocyte-derived plasma protein adiponectin acts as a platelet-derived growth factor-BB-binding protein and regulates growth factor-induced common postreceptor signal in vascular smooth muscle cell. Circulation 2002, 105:2893-2898.
6. Ouchi N, Arita Y, Kihara S, Nishida M, Matsuyama A, Okamoto Y, Ishigami M, Kuriyama H, Kishida K, Nishizawa H, Hotta K, Muraguchi M, Ohmoto Y, Yamashita S, Funahashi T, Matsuzawa Y: Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte derived macrophages. Circulation 2001, 103:1057-1063.
7. Matsubara M, Maruoka S, Katayose S: Inverse relationship between plasma adiponectin and leptin concentrations in normal-weight and obese women. Eur J Endocrinol 2002, 147:173-180.
8. Cianflone K, Vu H, Walsh M, Baldo A, Sniderman A: Metabolic response of Acylation Stimulating Protein to an oral fat load. J Lipid Res 1989, 30:1727-1733.
9. Charlesworth JA, Peake PW, Campbell LV, Pussell BA, O'Grady S, Tzilopoulos T: The influence of oral lipid loads on acylation stimulating protein (ASP) in healthy volunteers. Int J Obes Relat Metab Disord 1998, 22:1096-1102.
10. Halkes CJ, van Dijk H, de Jaegere PP, Plokker HW, van Der Helm Y, Erkelens DW, Castro CM: Postprandial increase of complement component 3 in normolipidemic patients with coronary artery disease: effects of expandeddose simvastatin. Arterioscler Thromb Vasc Biol 2001, 21:1526-1530.
11. Lopes HF, Martin KL, Nashar K, Morrow JD, Goodfriend TL, Egan BM: DASH diet lowers blood pressure and lipid-induced oxidative stress in obesity. Hypertension 2003, 41:422-430.
12. Pasternak RC: Report of the Adult Treatment Panel III: The 2001 National Cholesterol Education Program guidelines on the detection, evaluation and treatment of elevated cholesterol in adults. Cardiol Clin 2003, 21(3):393-398.
13. Zambon A, Hashimoto SI, Brunzell JD: Analysis of techniques to obtain plasma for measurement of levels of free fatty acids. J Lipid Res 1993, 34:1021-1028.
14. Barash H, Akov S: Improved 63Ni radiochemical assay of free fatty acids in plasma. Clin Chem 1987, 33:176-179.
15. De Bruin TW, Brouwer CB, Gimpel JA, Erkelens DW: Postprandial decrease in HDL-cholesterol and HDL apo A-I in normal subjects in relation to triglyceride metabolism. Am J Physiol 1991, 260(3 Pt 1):E492-E498.
16. Friedewald WT, Levy RI, Fredrickson DS: Estimation of the concentration of lowdensity lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972, 18:499-502.
17. Benzie IF, Strain JJ: The ferric reducing ability of plasma (FRAP) as a measure of "antioxidant power": The FRAP assay. Anal Biochem 1996, 239:70-76.
18. Benjamini Y, Hochberg Y: Controlling the false discovery rate: A practical and powerful approach to multiple testing. J R Stat Soc Ser B Methodol 1995, 57:89.300.
19. Mark AL, Correia ML, Rahmouni K, Haynes WG: Selective leptin resistance: A new concept in leptin physiology with cardiovascular implications. J Hypertens 2002, 20:1245-1250.
20. Landsberg L: Insulin-mediated sympathetic stimulation: role in the pathogenesis of obesity-related hypertension (or, how insulin affects blood pressure, and why). J Hypertens 2001, 19(3 Pt 2):523-528.
21. Masuo K, Mikami H, Itoh M, Ogihara T, Tuck ML: Sympathetic activity and body mass index contribute to blood pressure levels. Hypertens Res 2000, 23:303-310.
22. Leyva F, Godsland IF, Ghatei M, Proudler AJ, Aldis S, Walton C, Bloom S, Stevenson JC: Hyperleptinemia as a component of a metabolic syndrome of cardiovascular risk. Arterioscler Thromb Vasc Biol 1998, 18:928-933.
23. Maslowska M, Vu H, Phelis S, Sniderman AD, Rhode BM, Blank D, Cianflone K: Plasma acylation stimulating protein, adipsin and lipids in non-obese and obese populations. Eur J Clin Invest 1999, 29:679-686.
24. Meijssen S, van Dijk H, Verseyden C, Erkelens DW, Cabezas MC: Delayed and exaggerated postprandial complement component 3 response in familial combined hyperlipidemia. Arterioscler Thromb Vasc Biol 2002, 22:811-816.
25. Murray I, Sniderman AD, Cianflone K: Mice lacking acylation stimulating protein (ASP) have delayed postprandial triglyceride clearance. J Lipid Res 1999, 40:1671-1676.